Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression

Archives of Women's Mental Health

Volumn 14, Issue 1, 2011, Pages 49-53

  Rampono, Jonathan ^a,b   Teoh, Stephanie ^b   Hackett, L Peter ^c   Kohan, Rolland ^b   Ilett, Kenneth F ^c,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c Path West Laboratory Medicine   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Absolute infant dose; Breast milk; Desvenlafaxine; Lactation; Postnatal depression; Relative infant dose

Indexed keywords

DESVENLAFAXINE; DOMPERIDONE; LAMOTRIGINE; LEVONORGESTREL; LORAZEPAM; QUETIAPINE; TEMAZEPAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIPOLAR DISORDER; BIRTH WEIGHT; BODY WEIGHT; BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG MECHANISM; DRUG MILK LEVEL; FEMALE; GENERALIZED ANXIETY DISORDER; GESTATIONAL AGE; HUMAN; INFANT; LACTATION; MALE; MORNING DOSAGE; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; BREAST FEEDING; CYCLOHEXANOLS; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MALE; MILK, HUMAN;

EID: 79751529861     PISSN: 14341816     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00737-010-0188-9     Document Type: Article

References (15)

1. Bennett PN (1996) Use of the monographs on drugs. In: Bennett PN (ed) Drugs and human lactation, 2nd edn. Elsevier, Amsterdam, pp 67-74
2. GG Briggs PJ Ambrose KF Ilett LP Hackett, et al. 2009 Use of duloxetine in pregnancy and lactation Ann Pharmacother 43 1898 1902 10.1345/aph.1M317 19809008
3. AH Clayton SG Kornstein G Rosas C Guico-Pabia, et al. 2009 An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder CNS Spectr 14 183 195 19407730
4. WK Frankenburg J Dodds P Archer H Shapiro, et al. 1992 The Denver II: a major revision and restandardization of the Denver developmental screening test Pediatrics 89 91 97 1:STN:280:DyaK38%2FptlGjsA%3D%3D 1370185
5. V Hendrick L Altshuler A Wertheimer WA Dunn 2001 Venlafaxine and breast-feeding Am J Psychiatry 158 2089 2090 1:STN:280:DC%2BD3Mnot1aruw%3D%3D 10.1176/appi.ajp.158.12.2089-a 11729040
6. KF Ilett LP Hackett LJ Dusci MJ Roberts, et al. 1998 Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk Br J Clin Pharmacol 45 459 462 1:CAS:528:DyaK1cXjslGgtrY%3D 10.1046/j.1365-2125.1998. 00710.x 9643618 (Pubitemid 28227347)
7. KF Ilett JH Kristensen LP Hackett M Paech, et al. 2002 Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants Br J Clin Pharmacol 53 17 22 1:CAS:528:DC%2BD38XhtFWrsrc%3D 10.1046/j.0306-5251.2001.01518.x 11849190 (Pubitemid 34117734)
8. ED Lobo C Loghin MP Knadler T Quinlan, et al. 2008 Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women Clin Pharmacokinet 47 103 109 1:CAS:528:DC%2BD1cXjs1ejt78%3D 10.2165/00003088- 200847020-00003 18193916
9. A Lucas JA Gibbs RL Lyster JD Baum 1978 Creamatocrit: simple clinical technique for estimating fat concentration and energy value of human milk Br Med J (Clin Res Edn) 1 1018 1020 1:CAS:528:DyaE1cXksFynsbk%3D 10.1136/bmj.1.6119. 1018 (Pubitemid 8308864)
10. DJ Newport JC Ritchie BT Knight BA Glover, et al. 2009 Venlafaxine in human breast milk and nursing infant plasma: determination of exposure J Clin Psychiatry 70 1304 1310 1:CAS:528:DC%2BD1MXhtlSks7bL 10.4088/JCP.08m05001 19607765
11. GI Papakostas ME Thase M Fava JC Nelson, et al. 2007 Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents Biol Psychiatry 62 1217 1227 1:CAS:528:DC%2BD2sXht1ymu7jI 10.1016/j.biopsych.2007.03.027 17588546 (Pubitemid 350060895)
12. R Perry M Cassagnol 2009 Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder Clin Ther 31 1374 1404 1:CAS:528:DC%2BC3cXhtlWjtL%2FO 10.1016/j.clinthera.2009. 07.012 19698900
13. ME Thase 2008 Are SNRIs more effective than SSRIs? A review of the current state of the controversy Psychopharmacol Bull 41 58 85 18668017
14. Thomann P (1993) Non-compartmental analysis methods manual. In: Heinzel G, Woloszcak R, Thomann P (eds) TopFit 2.0 pharmacokinetic and pharmacodynamic data analysis system for the PC. Gustav Fischer, Stuttgart, pp 5-66
15. Wyeth Australia Pty Ltd. (2010) Pristiq Product Information. Wyeth Australia Pty Ltd., Baulkham Hills, Australia, pp 1-15. Available at: http://www.pbs.gov.au/html/healthpro/search/results?term=Pristiq& publication=GE. Accessed 12 Mar 2010